Health Canada just approved memantine (Ebixa) for moderate to severe Alzheimer's disease

February 2005

Health Canada just approved memantine (Ebixa) for moderate to severe Alzheimer's disease.

It's marketed under the brand name Namenda in the U.S.

Until now, there was no specific treatment approved for SEVERE Alzheimer's. The cholinesterase inhibitors (Aricept, Exelon, and Reminyl) are approved for MILD to moderate cases.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 120+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote